Bioqual Inc
OTC:BIOQ
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| US |
|
Bioqual Inc
OTC:BIOQ
|
33.5m USD |
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
394.1B USD |
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
203.3B USD |
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
188.3B USD |
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
119.5B USD |
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
81.8B USD |
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
89B AUD |
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
42.6B EUR |
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Market Distribution
| Min | -4 418 600% |
| 30th Percentile | -9.6% |
| Median | 3.1% |
| 70th Percentile | 11.3% |
| Max | 1 135 400% |
Other Profitability Ratios
Bioqual Inc
Glance View
Bioqual, Inc. engages in the provision and development of medical research and consulting services to commercial clients and government laboratories. The company is headquartered in Rockville, Maryland. The firm also performs in vitro contract research services. The company is involved in the evaluation of vaccines, vaccine therapeutics, microbicides, and drug therapies. The In vitro services include sample processing, virus stock generation, quantitation of infectious virus, virus neutralization assays, hemagglutination inhibition assay, quantitative PCR, antigen and antibody ELISA detection assays, flow cytometry, lymphocyte proliferation and other cell-based assays. The firm provides its services to the federal government, universities and the life science and pharmaceutical industries.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for Bioqual Inc is -1.3%, which is below its 3-year median of -0.2%.
Over the last 3 years, Bioqual Inc’s Net Margin has decreased from 7.9% to -1.3%. During this period, it reached a low of -4.2% on Nov 30, 2024 and a high of 8% on Nov 30, 2022.
